Cumberland Pharmaceutical... (CPIX)
4.38
0.25 (6.05%)
At close: Mar 28, 2025, 3:59 PM
4.25
-2.93%
After-hours: Mar 28, 2025, 06:02 PM EDT
Cumberland Pharmaceuticals Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
| Cash & Equivalents | 17,964.2B | 18.32M | 19.76M | 27.04M | 24.75M | 28.21M | 27.94M | 45.41M | 34.51M | 38.2M | 39.87M | 40.87M | 54.35M | 70.6M | 65.89M | 78.7M | 11.83M | 10.81M | 6.26M | 5.54M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 8.29M | 4.67M | 15.62M | 14.56M | 14.84M | 14.02M | 16.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | -662.01K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 13,789.5B | 15.5M | 10.05M | 12.47M | 14.89M | 18.85M | 2.53M | 2.49M | 2.12M | 1.89M | 1.79M | 1.35M | 645.37K | 67.85K | 102.79K | 369.79K | 3.45M | 2.69M | 25.9K | n/a |
| Receivables | 11,701.5B | 9.76M | 13.16M | 6.88M | 12.38M | 7.86M | 7.84M | 8.4M | 7.33M | 6.08M | 5.5M | 4.53M | 6.02M | 7.08M | 5.15M | 6.18M | 3.13M | 2.37M | 5.12M | 2.41M |
| Inventory | 4,000B | 4.61M | 9.4M | 8.43M | 10.64M | 8.87M | 27.83M | 6.74M | 5.37M | 4.27M | 5.6M | 5.72M | 6.22M | 5.77M | 7.68M | 4.82M | 1.76M | 949.11K | 671.1K | 546.38K |
| Other Current Assets | 2,786.5B | 3.03M | 3.08M | 6.68M | 2.2M | 5.22M | 2.96M | 3.47M | 2.71M | 4M | 5M | 3.54M | 3.96M | 3.85M | 2.32M | 3.47M | 988.52K | 651.42K | 596.36K | 93.72K |
| Total Current Assets | 36,452.2B | 35.71M | 45.87M | 45.69M | 49.97M | 50.16M | 74.87M | 68.68M | 65.55M | 67.11M | 70.81M | 68.68M | 87.23M | 87.31M | 81.04M | 93.17M | 17.71M | 14.79M | 12.64M | 8.59M |
| Property-Plant & Equipment | 6,454.3B | 7.04M | 5.5M | 1.47M | 2.6M | 3.71M | 771.21K | 528.88K | 464.45K | 536.45K | 651.03K | 880.65K | 1.19M | 1.12M | 1.22M | 918.41K | 432.41K | 459.84K | 365.77K | 373.94K |
| Goodwill & Intangibles | 18,887.4B | 23.52M | 31.5M | 24.84M | 29M | 31.8M | 34.44M | 21.44M | 22.15M | 21.17M | 21.57M | 15.5M | 9.48M | 7.02M | 7.43M | 7.96M | 8.53M | 9.15M | 9.83M | 36.98K |
| Total Long-Term Assets | 39,131.3B | 46.06M | 47.05M | 38.77M | 46.49M | 54.39M | 37.83M | 24.55M | 27.86M | 24.81M | 24.59M | 18.93M | 11.36M | 8.21M | 11.02M | 10.55M | 13.41M | 14.13M | 13.84M | 1.58M |
| Total Assets | 75,583.4B | 81.78M | 92.93M | 84.46M | 96.46M | 104.55M | 112.69M | 93.23M | 93.4M | 91.92M | 95.41M | 87.61M | 98.59M | 95.52M | 92.05M | 103.72M | 31.12M | 28.92M | 26.48M | 10.17M |
| Account Payables | 13.91M | 14.04M | 10.82M | 9.64M | 13.4M | 9.99M | 11.09M | 8.98M | 8.04M | 2.88M | 3.24M | 2.04M | 2.79M | 1.51M | 2.12M | 5.63M | 3.26M | 1.92M | 3.37M | 990.12K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 5.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.39M | n/a | 2.64M | 2.63M | 1.44M | 551.93K |
| Short-Term Debt | 5,456.5B | 348.09K | 172.91K | 969.68K | 3.2M | 920.43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.67M | 9.21M | 1.25M | 3.16M | 1.83M | 281.21K |
| Other Current Liabilities | 26,165.2B | 13.6M | 17.59M | 8.67M | 9.07M | 13.24M | 16.71M | 8.71M | 6.76M | 9.53M | 10.51M | 5.51M | 5.26M | 5.09M | 4.44M | 3.78M | 3.1M | 3.04M | 3.49M | 1.68M |
| Total Current Liabilities | 31,621.7B | 27.98M | 28.58M | 19.28M | 25.67M | 24.15M | 27.8M | 17.69M | 14.79M | 12.41M | 13.75M | 7.55M | 8.06M | 6.6M | 9.23M | 18.62M | 7.61M | 8.12M | 8.7M | 2.95M |
| Long-Term Debt | 15,115.9B | 18.08M | 20.79M | 15.09M | 16.06M | 20.58M | 20M | 9.8M | 4.1M | 1.7M | n/a | n/a | 4.97M | 4.86M | 5.11M | 10.95M | 5.58M | 916.66K | 3.58M | n/a |
| Other Long-Term Liabilities | 6,299.8B | 6.45M | 7.59M | 7.49M | 7.86M | 8.74M | 9.32M | 1.82M | 1.39M | 987.43K | 902.84K | 776.13K | n/a | 578.12K | n/a | 1.93M | 382.49K | 3.14M | 3.08M | n/a |
| Total Long-Term Liabilities | 21,415.7B | 24.53M | 28.37M | 22.58M | 23.92M | 29.31M | 29.32M | 11.62M | 5.49M | 2.69M | 902.84K | 776.13K | 4.97M | 6.08M | 5.11M | 12.88M | 5.96M | 4.05M | 6.66M | 988.96K |
| Total Liabilities | 53,037.4B | 52.52M | 56.95M | 41.86M | 49.59M | 53.46M | 57.12M | 29.31M | 20.28M | 15.1M | 14.65M | 8.32M | 13.03M | 12.68M | 14.34M | 31.5M | 13.56M | 12.17M | 15.36M | 3.94M |
| Total Debt | 20,572.4B | 18.43M | 20.96M | 16.06M | 17.08M | 21.5M | 20M | 9.8M | 4.1M | 1.7M | n/a | n/a | 4.36M | 5.44M | 7.8M | 20.16M | 6.83M | 4.08M | 5.41M | 281.21K |
| Common Stock | 46,821.4B | 47.09M | 47.47M | 48.45M | 49.12M | 49.91M | 51.1M | 52.41M | 54.64M | 57.34M | 61.94M | 63.07M | 67.2M | n/a | 70.78M | 1.93B | n/a | n/a | n/a | n/a |
| Retained Earnings | -23,967.9B | -17.49M | -11.21M | -5.64M | -2.13M | 1.21M | 4.75M | 11.71M | 18.6M | 19.55M | 18.82M | 16.39M | 18.5M | 12.66M | 7M | 4.54M | 1.45M | -3.32M | -7.36M | -11.76M |
| Comprehensive Income | n/a | n/a | n/a | 0.00 | -0.00 | -0.00 | -0.00 | 0.00 | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shareholders Equity | 22,853.5B | 29.6M | 36.27M | 42.81M | 46.99M | 51.12M | 55.84M | 64.12M | 73.25M | 76.89M | 80.76M | 79.47M | 85.7M | 82.93M | 77.78M | 72.25M | 17.55M | 16.75M | 11.13M | 6.23M |
| Total Investments | n/a | n/a | n/a | n/a | -662.01K | n/a | 8.29M | 4.67M | 15.62M | 14.56M | 14.84M | 14.02M | 16.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |